HDAC9 and neoplasm: Similarly, histone deacetylase inhibitors (HDAC inhibitors), while inhibiting tumor cell proliferation, can also disrupt the transcription balance of normal tissues, resulting in cardiovascular, hematopoietic, and nervous system side effects (275).